Главная › Рак простаты › Калифорния › San Francisco
Клинические исследования Рак простаты в городе San Francisco, CA
45 исследований по теме Рак простаты ищут участников в центрах в городе San Francisco и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Набор участниковФаза 3
- Kaiser Permanente-San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Набор участников
- Kaiser Permanente-San Francisco, San Francisco
Precision-Based Genomics in Prostate Cancer
Набор участниковНаблюдательное исследование
- University of California San Francisco, San Francisco
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Набор участниковФаза 3
- San Francisco VA Health Care System ( Site 0093), San Francisco
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Набор участниковФаза 3
- University of California San Francisco, San Francisco
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Набор участников
- University of California San Francisco, San Francisco
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Набор участниковФаза 3
- Kaiser Permanente-San Francisco, San Francisco
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Набор участниковФаза 2
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
Набор участниковНаблюдательное исследование
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study of Tarlatamab for People With Prostate Cancer
Набор участниковФаза 2
- University of California San Francisco, San Francisco
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Набор участниковФаза 1
- University of California, San Francisco, San Francisco
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Набор участниковНаблюдательное исследование
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Набор участниковФаза 3
- Research Site, San Francisco
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Набор участниковФаза 1
- University of California San Francisco, San Francisco
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Набор участниковФаза 2
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Набор участниковФаза 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Набор участниковФаза 1/2
- Research Site, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
Набор участниковФаза 1/2
- University of California San Francisco Cancer Center, San Francisco
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Набор участниковФаза 1
- University of California San Francisco, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Набор участниковФаза 1/2
- University of California, San Francisco, San Francisco
PSMA PET Combined With MRI for the Detection of PCa
Набор участниковФаза 3Приглашаются здоровые добровольцы
- University of California San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
Набор участниковФаза 1
- University of California, San Francisco, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Набор участниковФаза 1
- University of California San Francisco, San Francisco
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
Набор участниковНаблюдательное исследование
- University of California, San Francisco, San Francisco
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Набор участниковФаза 2
- University of California San Francisco, San Francisco
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Набор участниковФаза 1
- University of California San Francisco, San Francisco
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Набор участниковФаза 2
- University of California, San Francisco, San Francisco
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
Набор участниковФаза 1
- University of California, San Francisco, San Francisco
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Набор участниковФаза 2
- University of California, San Francisco, San Francisco
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- University of California, San Francisco, San Francisco
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Набор участников
- UCSF, San Francisco
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
Набор участниковРанняя фаза 1
- University of California, San Francisco, San Francisco
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Набор участников
- University of California, San Francisco
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Набор участниковФаза 3
- Kaiser Permanente-San Francisco, San Francisco
Mechanisms of Resistance to PSMA Radioligand Therapy
Набор участниковНаблюдательное исследование
- University of California, San Francisco, San Francisco
64Cu-GRIP B in Patients With Advanced Malignancies
Набор участниковФаза 1/2
- University of California, San Francisco, San Francisco
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
Набор участников
- San Francisco Veterans Affairs Medical Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Набор участниковФаза 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набор участниковФаза 1
- University of California San Francisco, San Francisco
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Набор участниковФаза 2
- University of California, San Francisco, San Francisco
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
Набор участников
- Zuckerberg San Francisco General Hospital, San Francisco
- San Francisco Veterans Administration Medical Center, San Francisco
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Набор участниковФаза 3
- Kaiser Permanente-San Francisco, San Francisco
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Набор участниковНаблюдательное исследование
- University of California, San Francisco, San Francisco
Исследования Рак простаты в других городах
- New York City, NY103 исследований
- Houston, TX76 исследований
- Los Angeles, CA61 исследование
- Boston, MA59 исследований
- St. Louis, MO46 исследований
- Chicago, IL45 исследований
- Philadelphia, PA44 исследований
- Baltimore, MD43 исследований
- Nashville, TN42 исследований
- Seattle, WA42 исследований
- Washington, DC38 исследований
- Dallas, TX36 исследований
Другие исследования в городе San Francisco
- Рак молочной железы43 исследований
- Немелкоклеточный рак легкого36 исследований
- Рак (все виды)35 исследований
- Сердечная недостаточность29 исследований
- Метастатический рак28 исследований
- Рак легких23 исследований
- Меланома22 исследований
- Рак поджелудочной железы20 исследований
- Рак яичников19 исследований
- Колоректальный рак18 исследований
- Сердечно-сосудистые заболевания18 исследований
- Глиобластома17 исследований
Источник: ClinicalTrials.gov, данные получены 5 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.